癫痫设备市场规模、份额和成长分析：按产品类型、最终用户、地区划分 - 产业预测，2024-2031 年

2022年癫痫设备市场规模为13亿美元，从2023年的14.2亿美元成长到2031年的28.7亿美元，预计复合年增长率为9.2%。

由于癫痫盛行率的增加、意识的提高以及医疗技术的进步等因素，癫痫设备市场正在显着增长。对植入式神经刺激设备和穿戴式癫痫监测设备等癫痫设备的需求不断增长，以改善癫痫发作的检测、管理和患者预后。然而，高成本、有限的报销政策以及对熟练专业人员的需求等挑战阻碍了市场的扩张。北美目前领先市场，但由于医疗基础设施的改善和癫痫管理意识的提高，亚太地区正在经历显着增长。主要趋势包括增加设备技术创新以及强调以患者为中心的解决方案。

目录

介绍

• 这项研究的目的
• 定义
• 市场范围

调查方法

• 资讯采购
• 二手资料来源和主要资料来源
• 市场规模预测
• 市场假设与限制

执行摘要

• 市场概况展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及展望

• 市场动态
  • 促进因素
  • 机会
  • 抑制因素
  • 任务
• 波特的分析

主要市场考察

• 技术分析
• 市场生态系统
• 专利分析
• 监管环境
• 创新矩阵
• 主要投资分析
• 关键成功因素
• 市场魅力指数
• 竞争程度

癫痫设备市场：依产品类型

• 市场概况
• 常规装置
  • 监控装置
  • 脑电图仪
  • 标准脑电图设备
  • 视讯脑电图设备
  • 其他/携带式脑电图设备
  • 肌电图仪
  • 脑磁图装置
  • 其他的
• 脑深部电刺激装置
• 穿戴式装置

癫痫设备市场：依最终用户分类

• 市场概况
• 医院
• 门诊手术中心
• 专科诊所
• 居家医疗
• 诊断中心

癫痫设备市场：按地区

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲地区

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要市场参与者所采取的策略
• 近期市集活动
• 主要企业市场占有率（2023年）

主要企业简介

• Medtronic plc（Ireland）
• Abbott Laboratories（United States）
• LivaNova PLC（United Kingdom）
• NeuroPace, Inc.（United States）
• Cyberonics, Inc.（United States）
• Nihon Kohden Corporation（Japan）
• Biotronik SE & Co. KG（Germany）
• Boston Scientific Corporation（United States）
• Elekta AB（Sweden）
• Natus Medical Incorporated（United States）
• NeuroSigma, Inc.（United States）
• Philips Healthcare（Netherlands）
• Magstim Company Limited（United Kingdom）
• BrainScope Company, Inc.（United States）
• Imec（Belgium）
• Jordan NeuroScience, Inc.（United States）
• Masimo Corporation（United States）
• Neuronetics, Inc.（United States）
• Nexstim Plc（Finland）
• Cadwell Industries, Inc.（United States）

Epilepsy Devices Market size was valued at USD 1.30 billion in 2022 and is poised to grow from USD 1.42 billion in 2023 to USD 2.87 billion by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031).

The Epilepsy Devices Market is seeing substantial growth driven by factors such as increasing incidence of epilepsy, heightened awareness, and advancements in medical technology. There is a rising demand for epilepsy devices, including implantable neurostimulators and wearable seizure monitoring devices, aimed at improving seizure detection, management, and patient outcomes. However, challenges such as high costs, limited reimbursement policies, and the requirement for skilled professionals hinder market expansion. North America currently leads the market, while the Asia-Pacific region is experiencing significant growth due to improving healthcare infrastructure and rising awareness about epilepsy management. Key trends include ongoing innovation in device technology and a focus on patient-centered solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Epilepsy Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Epilepsy Devices Market Segmental Analysis

The global epilepsy devices market is segmented based on product type, end-users, and region. Based on product type, the market is segmented into Conventional Devices (Monitoring Devices [EEG devices {Standard EEG devices, Video EEG devices, Other/Ambulatory EEG devices}, EMG devices, MEG devices, other monitoring devices], Deep Brain Stimulation Devices), and wearable devices. Based on End-users, the market is segmented into, Hospitals, Neurology Centers, Ambulatory Surgery Centers & Clinics, Diagnostic Centers, Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Epilepsy Devices Market

The rising global prevalence of epilepsy has significantly expanded the population in need of advanced medical treatments, driving demand for innovative interventions. Technological progress in epilepsy devices, such as implantable neurostimulators and responsive neurostimulation, has enhanced seizure management and improved patient outcomes. Additionally, increasing awareness of epilepsy and the significance of early diagnosis and intervention have positively influenced market dynamics.

Restraints in the Epilepsy Devices Market

One of the main challenges in the market is the high cost of advanced epilepsy devices, limiting their accessibility for a significant portion of the population, especially in regions with limited healthcare resources. Additionally, reimbursement policies and insurance coverage can also hinder widespread adoption. Another constraint is the requirement for skilled professionals to properly implement and monitor these devices, underscoring the importance of comprehensive healthcare infrastructure.

Market Trends of the Epilepsy Devices Market

There is a growing focus on wearable seizure monitoring devices, indicating a trend towards patient-centered and non-invasive solutions for continuous monitoring. Additionally, there is increasing attention on responsive neurostimulation technologies, which offer adaptive responses in real-time to abnormal brain activity detected. Personalized medicine is emerging as a significant trend, with an emphasis on customizing treatment approaches according to individual patient profiles.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Technology Analysis
• Ecosystem of the Market
• Patent Analysis
• Regulatory Landscape
• Innovation Matrix
• Top Investment Analysis
• Key Success Factor
• Market Attractive Index
• Degree of Competition

Epilepsy Devices Market by Product Type

• Market Overview
• Conventional Devices
  • Monitoring Devices
  • EEG devices
  • Standard EEG devices
  • Video EEG devices
  • Other/Ambulatory EEG devices
  • EMG devices
  • MEG devices
  • Other monitoring devices
• Deep Brain Stimulation Devices
• Wearable Devices

Epilepsy Devices Market by End User

• Market Overview
• Hospitals
• Ambulatory Surgical Centres
• Specialty Clinics
• Home Care Settings
• Diagnostic Centres

Epilepsy Devices Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LivaNova PLC (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroPace, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cyberonics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nihon Kohden Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biotronik SE & Co. KG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Boston Scientific Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Elekta AB (Sweden)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Natus Medical Incorporated (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NeuroSigma, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Magstim Company Limited (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BrainScope Company, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Imec (Belgium)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jordan NeuroScience, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Masimo Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Neuronetics, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nexstim Plc (Finland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cadwell Industries, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments